Literature DB >> 7713885

The C terminus of SecA is involved in both lipid binding and SecB binding.

E Breukink1, N Nouwen, A van Raalte, S Mizushima, J Tommassen, B de Kruijff.   

Abstract

Using C-terminal deletion mutations in secA, we localized the previously proposed (Breukink, E., Keller, R.C. A., and de Kruijff, B. (1993), FEBS Lett. 331, 19-24) second lipid binding site on SecA. Since removal of these residues completely abolished the property of SecA to cause aggregation of negatively charged phosphatidyl-glycerol vesicles, we conclude that the C-terminal 70 amino acid residues of SecA are involved in lipid-binding. The C-terminal 70 amino acid residues of SecA are important for efficient in vitro translocation of the SecB-dependent precursor of PhoE across inverted inner membrane vesicles. Moreover, in vivo studies showed that this region is essential for growth. SecB and a SecB-precursor complex were shown to inhibit the SecA-mediated lipid vesicle aggregation, suggesting that the overall acidic SecB protein binds at or near the second lipid binding site on SecA. This together with the observation that the SecA mutant protein lacking the C-terminal 70 residues had a strongly reduced ability to mediate binding of SecB-precursor complexes to inverted inner membrane vesicles demonstrates that the C terminus of SecA is also involved in SecB binding.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713885     DOI: 10.1074/jbc.270.14.7902

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Cross-talk between catalytic and regulatory elements in a DEAD motor domain is essential for SecA function.

Authors:  G Sianidis; S Karamanou; E Vrontou; K Boulias; K Repanas; N Kyrpides; A S Politou; A Economou
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

2.  Catabolic repression of secB expression is positively controlled by cyclic AMP (cAMP) receptor protein-cAMP complexes at the transcriptional level.

Authors:  H K Seoh; P C Tai
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

Review 3.  Protein targeting to the bacterial cytoplasmic membrane.

Authors:  P Fekkes; A J Driessen
Journal:  Microbiol Mol Biol Rev       Date:  1999-03       Impact factor: 11.056

4.  Biophysical characterization of the influence of salt on tetrameric SecB.

Authors:  C Dekker; B Agianian; M Weik; G Zaccai; J Kroon; P Gros; B de Kruijff
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

5.  Overproduction of SecA suppresses the export defect caused by a mutation in the gene encoding the Escherichia coli export chaperone secB.

Authors:  H A Cook; C A Kumamoto
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

6.  Sites of interaction between SecA and the chaperone SecB, two proteins involved in export.

Authors:  Linda L Randall; Jennine M Crane; Gseping Liu; Simon J S Hardy
Journal:  Protein Sci       Date:  2004-03-09       Impact factor: 6.725

Review 7.  The bacterial Sec-translocase: structure and mechanism.

Authors:  Jelger A Lycklama A Nijeholt; Arnold J M Driessen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-04-19       Impact factor: 6.237

8.  Direct identification of the site of binding on the chaperone SecB for the amino terminus of the translocon motor SecA.

Authors:  Linda L Randall; Michael T Henzl
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

9.  Using a low denaturant model to explore the conformational features of translocation-active SecA.

Authors:  Jenny L Maki; Beena Krishnan; Lila M Gierasch
Journal:  Biochemistry       Date:  2012-02-08       Impact factor: 3.162

10.  Iron is a ligand of SecA-like metal-binding domains in vivo.

Authors:  Tamar Cranford-Smith; Mohammed Jamshad; Mark Jeeves; Rachael A Chandler; Jack Yule; Ashley Robinson; Farhana Alam; Karl A Dunne; Edwin H Aponte Angarita; Mashael Alanazi; Cailean Carter; Ian R Henderson; Janet E Lovett; Peter Winn; Timothy Knowles; Damon Huber
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.